Two Sigma Advisers LP Takes Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Two Sigma Advisers LP bought a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 61,000 shares of the construction company's stock, valued at approximately $725,000. Two Sigma Advisers LP owned 0.07% of Aspen Aerogels as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also modified their holdings of ASPN. Sandia Investment Management LP bought a new position in Aspen Aerogels in the fourth quarter worth about $89,000. AlphaQuest LLC lifted its holdings in shares of Aspen Aerogels by 54.0% in the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock worth $135,000 after purchasing an additional 3,998 shares during the last quarter. KLP Kapitalforvaltning AS bought a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $164,000. Connors Investor Services Inc. acquired a new position in Aspen Aerogels during the 4th quarter valued at approximately $168,000. Finally, Journey Strategic Wealth LLC bought a new position in Aspen Aerogels during the 4th quarter worth $178,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ASPN has been the topic of a number of recent research reports. Barclays reiterated an "equal weight" rating and issued a $7.00 target price (down from $13.00) on shares of Aspen Aerogels in a research note on Thursday, May 29th. Seaport Res Ptn downgraded shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 12th. TD Cowen upgraded shares of Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th. Craig Hallum dropped their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. Finally, Roth Mkm reduced their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a research report on Friday, February 14th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $18.44.

Insider Transactions at Aspen Aerogels

In other news, CEO Donald R. Young bought 20,000 shares of the stock in a transaction dated Monday, May 12th. The stock was bought at an average cost of $5.35 per share, with a total value of $107,000.00. Following the purchase, the chief executive officer now owns 550,856 shares of the company's stock, valued at approximately $2,947,079.60. This represents a 3.77% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 4.30% of the company's stock.

Aspen Aerogels Price Performance

NYSE:ASPN traded down $0.02 on Thursday, reaching $5.90. The stock had a trading volume of 685,972 shares, compared to its average volume of 2,005,458. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $484.01 million, a P/E ratio of 36.85 and a beta of 2.72. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $33.15. The stock has a fifty day moving average price of $5.65 and a 200-day moving average price of $9.17.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its earnings results on Thursday, May 8th. The construction company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.01. The business had revenue of $78.72 million for the quarter, compared to the consensus estimate of $82.75 million. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. Aspen Aerogels's revenue was down 16.7% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.02) EPS. Research analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.